X4 Pharmaceuticals, Inc — SC 13D Filings
7 SC 13D filings on record
This page lists all SC 13D filings submitted to the SEC by X4 Pharmaceuticals, Inc (XFOR), sorted by most recent first. Each row links to the full filing on EdgarLookup. X4 Pharmaceuticals, Inc has filed 7 SC 13D documents with the SEC since 2010. To view all SEC filings by X4 Pharmaceuticals, Inc, see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B1
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | 0001072613-22-000489 | Jul 19, 2022 | — |
| SC 13D | SC 13D | 0001193125-19-083526 | Mar 22, 2019 | — |
| SC 13D | SCHEDULE 13D | 0001193125-18-343736 | Dec 6, 2018 | — |
| SC 13D | SC 13D | 0001193125-18-045947 | Feb 14, 2018 | — |
| SC 13D | SCHEDULE 13D | 0000947871-17-000977 | Nov 30, 2017 | — |
| SC 13D | SC 13D | 0001193125-17-355669 | Nov 29, 2017 | — |
| SC 13D | NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D | 0001072613-17-000603 | Nov 29, 2017 | — |